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favor of a more complex network of B12
production, uptake, and cycling.
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Eukaryotic microalgae and prokaryotic cyanobacte-
ria are the major components of the phytoplankton.
Determining factors that govern growth of these pri-
mary producers, and how they interact, is therefore
essential to understanding aquatic ecosystem pro-
ductivity. Over half of microalgal species represent-
ingmarine and freshwater habitats require for growth
the corrinoid cofactor B12, which is synthesized de
novo only by certain prokaryotes, including the ma-
jority of cyanobacteria. There are several chemical
variants of B12, which are not necessarily functionally
interchangeable. Cobalamin, the form bioavailable to
humans, has as its lower axial ligand 5,6-dimethyl-
benzimidazole (DMB). Here, we show that the abun-
dant marine cyanobacterium Synechococcus syn-
thesizes only pseudocobalamin, in which the lower
axial ligand is adenine. Moreover, bioinformatic
searches of over 100 sequenced cyanobacterial ge-
nomes for B12 biosynthesis genes, including those
involved in nucleotide loop assembly, suggest this
is the form synthesized by cyanobacteria more
broadly. We further demonstrate that pseudocobala-
min is several orders of magnitude less bioavailable
than cobalamin to several B12-dependentmicroalgae
representing diverse lineages. This indicates that the
two major phytoplankton groups use a different B12
currency. However, in an intriguing twist, some mi-
croalgal species can use pseudocobalamin if DMB
is provided, suggesting that they are able to remodel
the cofactor, whereas Synechococcus cannot. This
species-specific attribute implicates algal remodel-
ers as novel and keystone players of the B12 cycle,
transforming our perception of the dynamics and
complexity of the flux of this nutrient in aquatic
ecosystems.Cu
This is an open access article undINTRODUCTION
Eukaryotic microalgae are photosynthetic microbes estimated
to be responsible for up to 50% of global carbon fixation [1].
Elucidation of factors that control algal community structure
and dynamics is thus fundamental to understanding the global
cycling of carbon. Nutrients such as iron, nitrogen, and phos-
phorus clearly play an important role [2], but many microalgae
also require the vitamins B1 (thiamine), B7 (biotin), or B12 for
growth [3]. B12 is required as a cofactor for methionine synthase
(METH; EC 2.1.1.13) activity, a key enzyme of cellular one-car-
bon (C1) metabolism important for production of the universal
methyl donor S-adenosylmethionine (SAM), and for folate
cycling necessary for DNA synthesis [4]. Those algae that do
not need a supply of B12 cannot synthesize the vitamin; rather,
they possess an alternative form of methionine synthase
(METE; EC 2.1.1.14) that can catalyze the same reaction in a
B12-independent fashion [5, 6].
Measurement of B12 levels in the water column have indicated
concentrations of 10 pM in freshwater ecosystems [7] and are
often below the threshold of detection in certain marine habitats,
including large areas of the northeast Pacific margin [8]. The
scarcity of this micronutrient is therefore thought to limit
phytoplankton abundance [8], so competition for B12 among
those organisms that require/use it is likely. Indeed, field-enrich-
ment experiments found that, whereas N addition stimulated
all microbial growth, there was a specific growth enhancement
of phytoplankton >5 mm (i.e., the larger eukaryote fraction)
with B12 supplementation [9]. However, several recent studies
have demonstrated that heterotrophic bacteria can satisfy
microalgal requirements for B12 via mutualistic interactions
(e.g., [5, 10]).
Provision from prokaryotes is particularly pertinent because
the biosynthetic pathway of this cofactor is confined to certain
archaea and bacteria. B12 is an umbrella term that refers to
cobalt-containing corrinoids (ring-contracted tetrapyrroles),
which have upper and lower axial ligands to the cobalt ion (Fig-
ure 1A). The nature of these ligands varies, leading to diversity in
the structural forms of B12. Methylcobalamin, where the upper
axial ligand is a methyl group, is involved in methyl-transferrrent Biology 26, 999–1008, April 25, 2016 ª2016 The Authors 999
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
A B
Figure 1. Synechococcus Strains Synthesize Pseudocobalamin Rather Than Cobalamin
(A) Structural variants of B12.
(B) HPLC-MS extracted ion chromatograms for m/z 1355.5 cyanocobalamin and m/z 1344.5 cyanopseudocobalamin (see also Figure S1). The lower tracks
display the chromatograms for cell-free extracts derived from cultures of cyanobacterial species from Figure S2. Experiments were carried out in triplicate, and
one replicate representative of each strain is shown.reactions, whereas adenosylcobalamin (coenzyme B12) is used
for radical-based rearrangements and reductions [11]. The iden-
tity of the base found as the lower axial ligand, bound via a
nucleotide loop, may vary too. In cobalamin, the base is 5, 6-di-
methylbenzimidazole (DMB). Many bacteria, including methano-
gens and anaerobes such as Clostridium species, synthesize a
B12 vitamer known as pseudocobalamin [12, 13], which differs
from cobalamin in that DMB is replaced by adenine. Intrinsic
factor, the mammalian B12-binding protein important in uptake
from the gut, has a lower affinity for pseudocobalamin than
cobalamin [14]. Pseudocobalamin is therefore considered not
‘‘bioavailable’’ to humans, and the efficacy of vitamin supple-
ments produced from cyanobacteria such as Spirulina and
Aphanizomenon, which also contain pseudocobalamin, has
been questioned [15, 16].
Cyanobacteria are the numerically dominant photosynthetic
microbes in the marine environment [17]. Two cyanobacterial
strains, Crocosphaera watsonii WH8501 and Synechococcus
sp. WH7803, were reported to release B12 into themedia at rates
exceeding those estimated for the heterotrophic bacterium
Halomonas, suggesting that cyanobacteria might be the major
source of B12 for marine algae [18]. However, indications from
the early literature suggest consideration of algal specificity to-
ward different B12-like factors may be pertinent [19]. Here, we
investigate corrinoids in several strains of Synechococcus, an
abundant and ubiquitous marine cyanobacterium [17, 20]; the1000 Current Biology 26, 999–1008, April 25, 2016nature of their axial ligands; and their ability to support growth
of eukaryotic primary producers.
RESULTS
Synechococcus Species Make Only Pseudocobalamin
The biosynthesis of the corrinoid ring of B12 from the common
tetrapyrrole progenitor uroporphyrinogen III requires at least 20
enzymatic steps, and several routes are known [21]. In a
preliminary investigation, San˜udo-Wilhelmy et al. [22] searched
for the presence of B12-biosynthesis genes in 40 marine
cyanobacteria with sequenced genomes. They found that all
but one species had putative homologs for at least 11 of these
genes and so concluded that they were capable of making
B12. However, they did not investigate the genes involved in syn-
thesis of the lower axial ligand and so could not conclude
whether the cyanobacteria studied produced cobalamin or
pseudocobalamin. To refine the analysis of B12-biosynthesis
genes, we searched 123 sequenced cyanobacterial genomes
for all 20 genes of the corrinoid pathway. All but six species
contained at least 15/20 of these genes and were predicted
to be B12 producers (Data S1; Supplemental Experimental
Procedures). Additionally, we searched for genes involved in
DMB biosynthesis, for which two routes are currently known
[23, 24]. The BluB enzyme, first characterized in Sinorhizobium
meliloti (Rhizobia) makes DMB from riboflavin under aerobic
conditions [23]. Using this sequence as a query, no hits were
found in 118 cyanobacterial genomes including C. watsonii
WH8501 and Synechococcus sp. WH7803. For five species
(including three from the Fischerella genus), hits for BluB were
obtained: two were annotated as cob(II)yrinic acid a,c-diamide
reductase (CobR), which is an enzyme of an earlier stage of
B12 biosynthesis, whereas the others were unknown. In contrast,
BluB homologs were found in 80% of sequenced rhizobia
(227/284 genomes; Data S1C) and 60% of Rhodobacterales
species (77/128; Data S1D) including Mesorhizobium loti, Sino-
rhizobium meliloti, Rhizobium leguminosarum, and the marine
bacteriumDinoroseobacter shibae, all of which can support algal
B12-auxotrophic growth [10, 25]. More recently, a second route
for DMB biosynthesis was identified in the obligate anaerobic
bacterium Eubacterium limosum [24], and enzymes encoded
by the bzaABCDE operon were shown to direct DMB production
via an oxygen-sensitive reaction from the purine precursor
5-aminoimidazole ribotide (AIR) [24]. We found that none of the
cyanobacterial genomes encoded the full bzaABCDE operon
(Data S1B). Moreover, CobT, which is required for DMB activa-
tion, is absent from all but two cyanobacterial genomes. Taken
together, these searches suggest that the vastmajority of cyano-
bacteria cannot make DMB.
To validate the observations from the bioinformatics analysis,
we wanted to assess directly what corrinoids are synthesized by
cyanobacteria so investigated the B12 content of strains of
marine Synechococcus, because this is an ancient and ecolog-
ically abundant lineage [20] with a mean global abundance of
7.0 ± 0.3 3 1026 cells y1, high-biomass-specific CO2 fixation
rates [17, 26] and axenic strains are available. Corrinoids can
be extracted from cells as their cyano-derivatives and then
analyzed by high-performance liquid chromatography (HPLC)-
mass spectrometry (LC-MS). First, using purified cyanocobal-
amin (obtained commercially) and cyanopseudocobalamin,
prepared from Propionibacterium acidi-propionici [12], we
were able to distinguish the two variants of B12 by their different
retention times on the LC (Figure 1B) and different mass (Figures
S1A and S1B). Derivatized cell lysate obtained from axenic cul-
tures of the heterotrophic marine bacterium D. shibae DFL12T
contained only cyanocobalamin. We next tested five members
of the Synechococcus lineage representing different clades
and habitats (highlighted in red in Figure S2): coastal strain
CC9311 (sub-cluster [SC] 5.1A; clade I); oligotroph WH8102
(SC5.1A; clade III); WH7803 and WH7805 (SC5.1B; clades V
and VI, respectively) which are widely distributed in various
oceanic waters; and the estuarine strain WH5701 (SC5.2). A sin-
gle peak was observable in these samples at a retention time
consistent with the pseudocobalamin standard (Figure 1B),
and its identity was confirmed by MS (Figures S1D–S1H). To
facilitate subsequent physiological work, we also tested two
model freshwater cyanobacterial species Synechocystis sp.
PCC6803 and Synechococcus elongatus PCC7942, because
these species grow quickly and easily in the laboratory. Again,
cell lysates from these strains contained only pseudocobalamin
(Figures 1B, S1I, and S1J). Together, these data demonstrate
that the cyanobacterial species sampled here make only pseu-
docobalamin in axenic laboratory culture conditions.
However, some B12-synthesizing bacteria can modify endog-
enous B12 forms with an alternative base [27]. For instance,although Salmonella enterica cannot make DMB, it can import
it and then make cobalamin instead of pseudocobalamin [27].
To investigate whether Synechococcus can perform this so-
called ‘‘guided biosynthesis,’’ we grew strains WH8102 and
WH7803 (representing SC5.1A and 5.1B) in the presence of
pseudocobalamin and 1 mM DMB, but only pseudocobalamin
was detected (Figures 1B, S1K, and S1L).We conclude therefore
that Synechococcus cannot replace the adenine base with DMB
to make cobalamin.
Pseudocobalamin Is Orders of Magnitude Less
Bioavailable to Eukaryotic Algae
We next tested whether cyanobacterially derived B12 could be
utilized by eukaryotic algae. Cell-free extracts of S. elongatus
PCC7942 (pseudocobalamin producer) were unable to rescue
growth of the B12-dependent freshwater alga Lobomonas ros-
trata, whereas there is clear growth with the addition of extracts
of three rhizobial bacteria (Figure S3), which all encode BluB [28].
It is conceivable that the growth is due to other compounds in the
crude lysate, so this initial experiment was extended using the
purified compounds, cyanocobalamin and cyanopseudocobala-
min. Equivalent concentrations of each B12 variant were added
to axenic cultures of B12-dependent microalgae from different
algal lineages: marine species Ostreococcus tauri (Chlorophyta,
Mamiellophyceae); Amphidinium carterae (Alveolata, Dinoflagel-
late); Pavlova lutheri (Haptophyta, Prymnesiophyceae); Thalas-
siosira pseudonana (Heterokontophyta, Coscinodiscophyceae);
Aureococcus anophagefferens (Heterokontophyta, Pelagophy-
ceae); and the freshwater species Euglena gracilis (Excavata,
Euglenozoa) and L. rostrata (Chlorophyta, Volvocales). We also
tested a B12-dependent metE mutant of Chlamydomonas
reinhardtii (Chlorophyta, Volvocales) [29]. When pseudocobala-
min was supplied at a concentration of 0.07 or 0.7 nM, we
observed little or no growth in any of the marine species, nor
with the C. reinhardtii metE mutant or L. rostrata. This is in
contrast to cobalamin, which supported growth of all algal cul-
tures at equivalent concentrations (Figure 2; Student’s t test;
p < 0.05; n = 3). For O. tauri, A. carterae, and T. pseudonana,
and to a lesser extent the C. reinhardtii metE mutant, provision
of pseudocobalamin at 7 nM (10 mg/l) supported growth to a
similar extent as cobalamin (Figures 2A, 2B, 2D, and 2H),
although this amount is significantly higher than found in natural
ecosystems (with reported concentrations ranging from below
the detection threshold to 0.03 nM across large areas of the
northeast Pacific margin, for instance) [7, 8]. One way to
compare the efficacy of the different B12 variants is to carry out
dose-response experiments, which enable determination of an
EC50 (that is the effective concentration required to support
half-maximal biomass accumulation) and also provide an indica-
tion of the minimum amount needed to observe any growth, and
so we carried these out with the C. reinhardtii metEmutant. Fig-
ure S4 shows that the EC50 was 0.07 nM for cobalamin,
compared to 7 nM (100-fold higher) for pseudocobalamin.
In addition, it is clear that even the highest concentration of pseu-
docobalamin used (40 nM) is not saturating, whereas 0.2 nM
cobalamin supports maximum growth. For E. gracilis, some
growth was observed even at the lowest pseudocobalamin con-
centration, but it was still significantly lower than with cobalamin
(Figure 2G). Thus, pseudocobalamin is orders of magnitude lessCurrent Biology 26, 999–1008, April 25, 2016 1001
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Figure 2. Pseudocobalamin Poorly Sup-
ports Growth of B12-Dependent Eukaryotic
Algae
(A–H) Growth yield (OD730) of algae in liquid me-
dium supplemented with or without cyanocobal-
amin or cyanopseudocobalamin (at 0.07, 0.7, or
7 nM) in batch culture after at least two transfers
(until the cells had died in the B12 treatment).
(A) O. tauri, (B) A. carterae, (C) P. lutheri, (D)
T. pseudonana, (E) A. anophagefferens, (F)
L. rostrata, (G) E. gracilis, and (H)C. reinhardtiiB12-
dependent metE mutants are shown [29]. Cbl,
cyanocobalamin; PsCbl, cyanopseudocobalamin.
*p% 0.05; **p% 0.01; ***p% 0.001 comparedwith
the equivalent concentration of Cbl (two-tailed
Student’s t test; mean ± SEM; n = 3). See also
Figures S3 and S4.bioavailable to eukaryotic algae. It is notable to mention that
E. gracilis has also been demonstrated to encode a B12-depen-
dent (type II) ribonucleotide reductase [30], which could ac-
count for the growth response to pseudocobalamin observed
in this alga.
We reasoned that the reduced ability of pseudocobalamin to
support growth of algal B12-auxotrophs may be either because
the molecule cannot be used as a cofactor or because it does
not get transported into algal cells. To investigate the latter pos-
sibility, we took advantage of the presence of B12-responsive
genes previously identified in the marine diatom Phaeodactylum
tricornutum and C. reinhardtii [31, 32]. These algae do not need
B12 for growth but will uptake and use it if it is available [5, 6].
Several genes in these algae are responsive to B12: METE (in
P. tricornutum and C. reinhardtii) [6, 31, 32]; CBA1, encoding a
novel cobalamin acquisition protein (in P. tricornutum only)
[31]; and S-adenosylhomocysteine hydrolase, SAHH (in
C. reinhardtii only) [32]. Using qRT-PCR, we analyzed their
expression in cells grown in the presence of 0.7 nM cobalamin1002 Current Biology 26, 999–1008, April 25, 2016or pseudocobalamin. For P. tricornutum,
both forms of B12 resulted in downregula-
tion of METE, but the effect was less
pronounced with pseudocobalamin com-
pared to that with cobalamin (Student’s
t test; p < 0.001; n = 3; Figure 3A). As pre-
viously demonstrated, cobalamin sup-
pressed CBA1 [31], but this gene was
significantly upregulated by pseudoco-
balamin (Student’s t test; p < 0.05;
n = 3; Figure 3A). In C. reinhardtii, both
METE (Student’s t test; p < 0.05; n = 3)
and SAHH (Student’s t test; p < 0.01;
n = 3) were downregulated relative to
the no supplementation control (Fig-
ure 3B) with both forms of B12. Subse-
quent western blot analysis using poly-
clonal antibodies against C. reinhardtii
METE protein [32] demonstrated a
modest reduction of METE abundance
when cells were grown with pseudocoba-
lamin, although not to the same extent ascobalamin (Figure S5). Nonetheless, the effect of pseudocobala-
min on the expression of these four B12-responsive genes indi-
cates that the molecule can enter both C. reinhardtii and
P. tricornutum cells.
Certain Algae Are Capable of Remodeling
Pseudocobalamin
By analogy with the guided biosynthesis described earlier, some
bacteria that cannot synthesize B12 de novo can modify im-
ported forms with an alternative base, via ‘‘corrinoid re-
modeling’’ [33, 34]. To investigate this possibility in algae, we
grew B12-requiring species in the presence of pseudocobalamin
and a range of DMB concentrations. For most, growth was not
restored by DMB supplementation (Figures 4A, 4B, and 4D–
4G). However, for P. lutheri and the C. reinhardtii metE mutant,
addition of DMB alongside pseudocobalamin rescued growth
to the same extent as cobalamin (Figures 4C and 4H). A dose-
response experiment with P. lutheri established an EC50 value
of 18 pM for cobalamin (Figure 5A). A similar experiment with
BA Figure 3. Pseudocobalamin Affects Expres-
sion of B12-Responsive Genes inP. tricornu-
tum and C. reinhardtii
(A and B) qRT-PCR analysis of (A)METE andCBA1
expression in P. tricornutum and (B) METE and
SAHH expression in C. reinhardtii, without B12 or
with 0.7 nM Cbl/PsCbl. Expression was normal-
ized using three housekeeping genes: Histone H4;
30S, ribosomal protein S1, RPS; and TATA box-
binding protein, TBP for P. tricornutum and re-
ceptor of activated protein kinase C 1, RACK 1;
Actin, ACT; ubiquitin, UBQ for C. reinhardtii. *p%
0.05; **p % 0.01; ***p % 0.001 compared to the
B12 treatment (two-tailed Student’s t test;
mean ± SEM; n = 3). See also Figure S5.a fixed concentration (0.7 nM) of pseudocobalamin but varying
the amount of DMB revealed a similar EC50 (23 pM; Figure 5B).
Interestingly, an equivalent dose-response curve (and EC50
value:26 pM) was observed when cells were grown in medium
made using natural filtered seawater rather than artificial sea
salts. Thus, the level of DMB in the natural filtered seawater is
not sufficient to allow remodeling; otherwise, the dose-response
curve would be shifted to the left. That comparable levels of B12
andDMB (at a fixed level of pseudocobalamin) are able to rescue
B12-dependent growth implies that P. lutheri is remodeling pseu-
docobalamin with DMB to generate cobalamin. Dosage experi-
ments with the C. reinhardtii B12-dependent metE mutant also
identified similar EC50 values of 28 pM and 70 pM for cobal-
amin and DMB, respectively (Figures 5C and 5D). In this case,
the EC50 value for DMB was slightly higher than cobalamin. We
also tested whether C. reinhardtii is capable of de novo lower-
loop synthesis and grew the C. reinhardtii B12-dependent metE
mutant with DMB, alongside (dicyano)cobinamide, a B12 precur-
sor that lacks the DMB ribonucleotide tail, but no restoration of
growth was observed (Figure 6A).
Our data indicate that, of eight diverse algal species studied,
six do not appear to be able to use exogenous DMB. Neverthe-
less, the observation that growth of the C. reinhardtii B12-
dependent metE mutant (alongside that of P. lutheri) with
pseudocobalamin is restored by DMB provision suggests that
these algae are able to chemically modify pseudocobalamin
to a form that can support B12-auxotrophic growth. To test
more directly whether pseudocobalamin is being remodeled,
we grew samples of C. reinhardtii in the presence of (1) cobal-
amin, (2) pseudocobalamin (1 nM), and (3) pseudocobalamin
(1 nM) +DMB (1 mM) and prepared cell lysate for LC-MS analysis.
However, we could not detect any form of B12 from lysed cells.
We infer from this that intracellular B12 levels are extremely
low, i.e., the quantity from13 1010 cells is below the threshold
detection of the LC-MS (which in our system is 13 1012 mole-
cules). Without a clear idea of what order of magnitude more
biomass would be required and constrained by the limitations
of scale, we turned to alternativemeans of characterizing remod-
eling activity and investigated the effect of DMB + pseudocoba-
lamin on gene expression in C. reinhardtii. Previously, we had
generated several transgenic lines of C. reinhardtii expressing
the B12-responsive element of the METE gene fused to the
BLE gene, which confers resistance to the antibiotic Zeocin
[32]. This reporter gene construct enables rapid and easy mea-
surement of B12-responsive gene expression, whereby growthwith cobalamin represses expression of BLE so that cells die in
the presence of Zeocin (Figure 6B). In contrast, pseudocobala-
min alone had little effect, but the inclusion of DMB impaired
growth to the same extent as cobalamin, demonstrating that
C. reinhardtii converts DMB and pseudocobalamin into a form
that is able to repress the METE promoter.
The pathway for pseudocobalamin remodeling has been
investigated previously in the purple bacterium Rhodobacter
sphaeroides, and cobinamide amidohydrolase (CbiZ) and cobi-
namide-phosphate synthase (CbiB) have been implicated in
this process [34]. We could not identify cbiZ or cbiB in any of
the algal genomes we analyzed. We therefore searched for pro-
teins shown to be involved in lower-loop assembly and activation
[34] in S. enterica (CobT, CobS, and CobC) [27], where mutants
of CobT are unable to incorporate exogenous DMB (Figure 6C).
We identified genes encoding all three of these proteins in
C. reinhardtii, which exhibits the remodeling phenotype (Table
S1; Figure 5). In contrast, BLASTP searches of the genomes of
O. tauri and T. pseudonana, species that do not appear to
remodel, were negative for CobT and CobS. Although a hit for
CobC was identified in T. pseudonana, it should be noted that
CobC catalyzes a dephosphorylation step [21, 27], and therefore
BLAST searches may retrieve genes encoding unrelated phos-
phatases. Interestingly, we identified hits for CobT and CobC,
but not CobS, in A. anophagefferens, which can use pseudoco-
balamin with DMB, but only with very high levels of the latter
(10 mM; Figure 4E). Transcript sequences for P. lutheri are
available via the Marine Microbial Eukaryote Transcriptome
Sequencing Project (MMETSP), a database of 396 unique strains
representing ecologically significant and taxonomically diverse
marine microbial eukaryotes [35]. This alga, which can use pseu-
docobalamin alongside DMB, also expressesCOBT,COBS, and
COBC (Data S2A). Thus, the presence of these novel proteins
correlates with the ability to remodel pseudocobalamin, impli-
cating them in B12 metabolism. We also identified another 46
candidate remodelers in the MMETSP (Data S2A), including
several that encodedMETE, and so are likeC. reinhardtii in being
independent of a source of B12 for growth. In total, the potential
remodelers represented 11% of unique strains and included
representatives of the higher class levels Alveolata, Strameno-
pila, Hacrobia, and Viridiplantae (Data S2B). Incidentally, none
of the sequenced Synechococcus genomes encode CobT
(Data S1), which might explain why Synechococcus strains
cannot remodel pseudocobalamin to cobalamin in the presence
of DMB (Figure 1B).Current Biology 26, 999–1008, April 25, 2016 1003
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Figure 4. Provision of Lower Ligand Sub-
strate DMB Together with Pseudoco-
balamin Can Support Growth of Certain
B12-Dependent Algae
(A–H) Species were grown in liquid medium (Table
S2) without or with 0.7 nM cobalamin (open bars)
or 0.7 nM pseudocobalamin (shaded bars) in the
presence of different DMB concentrations in batch
culture over several transfers or until the cells had
died in the B12 treatment. (A) O. tauri (OTH95),
(B) A. carteri, (C) P. lutheri, (D) T. pseudonana, (E)
A. anophagefferens, (F) L. rostrata, (G) E. gracilis,
and (H) C. reinhardtii, B12-dependent evolved
(metE) mutant lines are shown [29]. Optical den-
sity (OD730) was used to quantify growth (mean ±
SEM; n = 3).DISCUSSION
Eukaryotic microalgae and cyanobacteria are the major com-
ponents of the phytoplankton in marine and freshwater sys-
tems. Because they both inhabit the photic zone, they will
compete for resources including light and limiting nutrients
such as nitrogen and Fe. We have demonstrated that, in
contrast to heterotrophic bacteria such as D. shibae (and
certain rhizobial bacteria) [28] that make cobalamin, members
of the ubiquitous marine Synechococcus genus synthesize
only pseudocobalamin, in which the lower base is adenine
instead of DMB (Figure 1). Moreover, a survey of diverse cya-
nobacterial genomes, encompassing marine and freshwater
species, showed the vast majority do not encode bluB or the
bzaABCDE operon (Data S1) [23, 24]. This strongly suggests1004 Current Biology 26, 999–1008, April 25, 2016that pseudocobalamin is the major form
of B12 synthesized by most if not all
cyanobacteria.
We found that pseudocobalamin is
considerably less bioavailable than
cobalamin to several B12-dependent
algae (Figure 2). This reduced bioavail-
ability suggests these organisms are
compromised in their ability to acquire
or use pseudocobalamin as a cofactor.
Human intrinsic factor, part of the B12
uptake system in the gut, exhibits a
500-fold-lower binding affinity for pseu-
docobalamin [14], thus reducing the
bioavailability of the compound to hu-
mans. In algae, currently only one protein
has been implicated in B12 uptake [31]
(CBA1), although the precise molecular
mechanism and role of CBA1 in B12 bind-
ing are not fully understood. Neverthe-
less, the ability of pseudocobalamin to
affect the expression of algal B12-respon-
sive genes (Figure 3) and protein levels
(Figure S5) suggests this compound can
enter algal cells, albeit that it has the
opposite effect on CBA1 to cobalamin,
suggesting that the cells are experiencingcobalamin deficiency. Transport of pseudocobalamin into the
cell is also indicated by our observed remodeling of pseudoco-
balamin in C. reinhardtii and P. lutheri following DMB addition
(Figures 4 and 5). The identification of genes encoding enzymes
of lower ligand activation (COBT) and nucleotide-loop assembly
(COBS) [27] in these algae (Table S1) provides a likely mecha-
nism for corrinoid remodeling. We found no evidence of
secretory peptide signals in C. reinhardtii COBT or COBS using
the green algal subcellular localization tool ‘‘PredAlgo’’ [36],
implying that remodeling takes place within the cell and
providing further support for the ability of pseudocobalamin to
be taken up. Whether these genes have been acquired through
lateral gene transfer from a bacterial source, which is thought
to be the case for E. coli [37], remains unknown. However, of
the non-algal sequences retrieved via a BLAST search of the
A B
C D
Figure 5. Certain Algae Can Remodel the
Lower Axial Ligand of Pseudocobalamin
with Exogenously Supplied DMB
(A and B) Relative growth yield of (A) P. lutheri cells
supplemented with different concentrations of
cobalamin after 19 days (values of OD730 were
normalized as a proportion of growth at 1,000 pM
B12) or (B) P. lutheri cells supplemented with
different concentrations of DMB in the presence of
0.7 nMpseudocobalamin (after 19 days) in artificial
seawater or natural filtered seawater (values of
OD730 normalized to growth at 1,000 pM DMB).
(C and D) Equivalent experiments with C. rein-
hardtii, evolved B12-dependent metE mutant [29]
are displayed in (C) and (D) after 96 hr growth
(mean ± SEM; n = 3).NCBI non-redundant database with the C. reinhardtii COBT/
COBS, top hits were derived from the amphipod-associated pro-
tist species Aphanomyces astaci (4e57) and Sphaeroforma
arctica (7e77), respectively. A broader phylogenetic analysis
of COB genes will be integral to further understanding of what,
at a first glance, appears to be an intriguing evolutionary history.
Because algae rely on B12 for METH [5], the function of pseudo-
cobalamin as a cofactor for this enzyme is also an important
question. Structural data available for the B12-binding pocket
and the active site of METH [38, 39] implicate several amino
acids in B12 binding, with the DMB ‘‘tail’’ buried within a cleft ofA
B
C
Currentthe active site [40]. Because pseudoco-
balamin contains an alternative lower
base to B12, it seems plausible that algal
METH proteins may have reduced bind-
ing affinity for pseudocobalamin.The combination of DMB with pseudocobalamin improves
the bioavailability to certain algae. We infer from this that
these remodeling algae are able to generate cobalamin from
pseudocobalamin + DMB, although we were unable to measure
detectable levels of any form of B12 in C. reinhardtii cells grown
under these conditions. It is possible therefore that another form
of the vitamin is being generated, though we deem this unlikely.
In any case, our results highlight the importance of considering
environmental concentrations of DMB. A bioassay to measure
free DMB concentrations was recently reported [41]. Analysis
of samples derived from host-associated (termite/rumen) andFigure 6. Further Characterization of the
Remodeling Phenotype
(A) Relative growth yield (OD730) of C. reinhardtii
B12-dependent mutant grown with DMB alongside
(dicyano)cobinamide, a B12 precursor that lacks
the DMB ribonucleotide tail. Cells were grown in
liquid medium (Table S2) with 0.7 nM cobalamin
(open bars), 0.7 nM pseudocobalamin (gray bars),
or 0.7 nM (dicyano)cobinamide (black bars) in the
presence of different DMB concentrations.
(B) Relative growth yield (OD730) of C. reinhardtii
reporter line containing a Zeocin resistance gene
controlled by theMETE promoter [32] after 13 days
in the presence (white bar) or absence (black bar)
of DMB (1 mM) and 20 mg/ml Zeocin without or with
0.7 nM cobalamin or pseudocobalamin. Values of
OD730 were normalized as a proportion of growth
with no B12 (mean ± SEM; n = 3).
(C) The pathway for the activation of DMB and
nucleotide loop assembly in S. enterica (adapted
from [27]). CobT catalyzes the attachment of a
phosphoribose moiety derived from nicotinate
mononucleotide to form a-ribazole phosphate.
CobS and CobC catalyze the attachment of the
activated base to the cobamide precursor (GDP-
cobinamide).
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Figure 7. Complex B12 Cycling in a Hypothetical Marine Microbial
Community
Cobalamin produced by heterotrophic bacteria such asDinoroseobacter sp. is
directly usable by algal B12 auxotrophs representing major marine taxa,
whereas cyanobacterially derived pseudocobalamin is not. However, those
algae like P. lutheri capable of remodelling can access this essential cofactor if
DMB is also present.natural environmental samples (Eucalyptus grove soil/creek wa-
ter) determined concentrations in thepicomolar and sub-picomo-
lar range. Our observation that P. lutheri (whose growth can be
supported by pseudocobalamin +DMB) could not grow in natural
seawater from the English Channel supplemented with pseudo-
cobalamin (Figure 5B) suggests DMB levels were not sufficient
in these coastal waters to support remodeling. Nevertheless,
furtherwork is required toquantifyDMB inmarine (and freshwater)
environments more broadly. In a similar vein, a recent field study
by Heal et al. [42] quantified the relative abundance of four upper
axial variants of B12 (CN, Me, Ado, and OH) in estuarine waters of
the Puget Sound, but levels of lower axial ligand variants are
unknown.
Representatives of all major algal lineages require B12, yet its
biosynthesis is limited to a subset of prokaryotes. As such, the
flux of B12 betweenmicrobes is integral to the growth of auxotro-
phic species. Our results imply heterotrophic bacteria are likely
to be a more important source of B12 for eukaryotic algae than
cyanobacteria. An increasing body of evidence provided by
this study and others [33, 34, 43, 44] suggests the relationship
between requirers and providers has become blurred by the ex-
istence of scavengers and remodelers. That different B12 forms
are not functionally equivalent between organisms means that
biochemical transformations between vitamer classes are
essential for this micronutrient to reach different members of
the community. This complicates our current view of B12 cycling
in aquatic environments (Figure 7). Whether cyanobacteria syn-
thesize a currency of B12 that is inaccessible to competing eu-
karyotic microbes as a strategy to exclude competitors remains
unknown. Nevertheless, the observation that certain algae
possess a counter-mechanism to convert pseudocobalamin to
a bioavailable form suggests the selective pressure to devise1006 Current Biology 26, 999–1008, April 25, 2016and refine strategies of B12 acquisition/utilization in order to
enhance accessibility to this limiting micronutrient is strong. In
any case, the importance of B12 and its derivatives in structuring
microbial communities in aquatic ecosystems may have been
previously underestimated.
EXPERIMENTAL PROCEDURES
Bioinformatics Approaches
A full description of sequence similarity search parameters is provided in the
Supplemental Experimental Procedures.
Chemicals
Upper axial cyano forms of cobalamin/pseudocobalamin were used for all
B12-amendment experiments. Cyanocobalamin was purchased from Sigma-
Aldrich UK. Cyanopseudocobalamin was prepared by guided biosynthesis
from a culture of Propionibacterium acidi-propionici DSM 20273 as described
previously and confirmed by UV-Vis, circular dichroism (CD), mass, and nu-
clear magnetic resonance (NMR) spectroscopic analysis [12].
Strains and Growth Conditions
Details of microbial strains and culture conditions are provided in the Supple-
mental Experimental Procedures and Table S2.
Molecular Methods
RNA Extraction and qRT-PCR
Total RNA was extracted [6] and treated with the Ambion Turbo DNase-Free
Kit to remove genomic DNA. RNA was reverse transcribed into cDNA with
SuperScript II (Invitrogen). Details of qRT-PCR are given in the Supplemental
Experimental Procedures and Table S3.
Western Blotting
Total protein was extracted and western blot experiments performed as
described in [32].
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